Vor Biopharma, Inc. (VOR)
22.71
-0.65
(-2.78%)
USD |
NASDAQ |
Aug 24, 16:00
22.71
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Total Liabilities (Quarterly) : 681.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 681.25M |
| March 31, 2026 | 657.17M |
| December 31, 2025 | 629.32M |
| September 30, 2025 | 2.402B |
| June 30, 2025 | 1.711B |
| March 31, 2025 | 43.24M |
| December 31, 2024 | 56.35M |
| September 30, 2024 | 43.04M |
| June 30, 2024 | 43.51M |
| March 31, 2024 | 44.00M |
| December 31, 2023 | 59.10M |
| September 30, 2023 | 48.24M |
| June 30, 2023 | 46.54M |
| March 31, 2023 | 47.32M |
| Date | Value |
|---|---|
| December 31, 2022 | 48.76M |
| September 30, 2022 | 47.64M |
| June 30, 2022 | 49.64M |
| March 31, 2022 | 39.82M |
| December 31, 2021 | 26.33M |
| September 30, 2021 | 25.68M |
| June 30, 2021 | 25.04M |
| March 31, 2021 | 25.75M |
| December 31, 2020 | 27.64M |
| September 30, 2020 | 25.33M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.186M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | 291.86M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 481.05M |
| Shareholders Equity (Quarterly) | -200.20M |
| Debt to Equity Ratio | -0.0144 |
| Current Ratio | 19.15 |
| Net Debt Paydown Yield | 0.56% |